Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1240237.RA-7MuiT9f-T2qZaNNdI9hUsqEkjhBv_FYlI6b01sPDqw#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 21715317 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[In the B-cell lineage, CD160 is a tumor-specific antigen known to mediate cellular activation signals in CLL, and is a novel target for therapeutic manipulation and monitoring of minimal residual disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.